INTRODUCTION {#S1}
============

Chondrosarcomas of primary lung parenchymal origin are an extremely rare pathology with most descriptions coming from a series of case reports and small case series. These tumors can present as centrally located, parenchymal masses. Diagnosis requires extensive workup to exclude alternative etiology and to confirm diagnosis. To date, 28 cases, not including the current study, of this pathology have been reported. Herein, we present a case with biopsy-proven primary pulmonary chondrosarcoma and a brief literature review of similar cases.

CASE REPORT {#S2}
===========

A 23-year-old Caucasian male presented to a cardiothoracic surgery clinic for follow-up of a lung mass. The mass was identified on chest X-ray and computed tomography (CT) chest studies that were performed for the evaluation of a non-productive cough, fever, and 10 pounds weight loss.

On physical examination, the patient exhibited mild expiratory wheezing bilaterally. Pertinent laboratory results showed hypercalcemia. Pulmonary function tests were indicative of an obstructive lung disease; however, a bronchoscopy examination was unremarkable. Chest X-ray and contrast-enhanced CT were performed, revealing the presence of a large mass with several intrinsic calcifications in the upper lobe of the right lung along the paramediastinum \[[Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. An ultrasound-guided procedure was conducted to localize the lesion and biopsy the surrounding lymph nodes and was indicative of low-grade cartilaginous neoplasm, presumed to be either chondroma or teratoma.

![Chest radiograph frontal (a) and lateral (b) views of a 23-year-old male demonstrate rounded mass-like opacity (arrows) along the superior right paramediastinal border in the right upper lobe.](JCIS-10-3-g001){#F1}

![Contrast-enhanced computed tomography chest in axial (a and b), coronal (c), and sagittal (d) views of a 23-year-old male revealed a large soft tissue mass in the right upper lobe (thick arrows) along the right paramediastinal border abutting the adjacent mediastinal vascular structures (thin arrows), with multiple intrinsic calcifications (arrowhead). Surgery resection of the mass was performed and the lesion proved to be a low-grade primary lung chondrosarcoma.](JCIS-10-3-g002){#F2}

An exploratory right video-assisted thoracoscopic surgery was performed as primary treatment. The operation revealed an intraparenchymal central mass in the right upper lobe \[[Figure 3](#F3){ref-type="fig"}\] adherent to the mediastinum adjusted to the main pulmonary artery, thus necessitating a lobectomy. Postsurgical CT scan of the chest and bone scan using Tc-99m diphosphate revealed no residual tumor or secondary lesions, respectively.

![Resected 5 cm primary chondrosarcoma from a 23-year-old male from the upper lobe of right lung through exploratory video-assisted thoracoscopic surgery, (a and b) gross appearance of resected mass, (c-f) histopathological findings of primary pulmonary chondrosarcoma with H and E stain, arrows point toward binuclear chondrocytes with nuclear crowding, which suggest the presence of a low-grade chondrosarcoma.](JCIS-10-3-g003){#F3}

A histopathological review revealed a well-demarcated lobulated, rubbery, and cartilaginous tumor with a focal necrotic appearance and calcifications. The lesion had stromal hyalinization and prominent stromal vessels with mild atypia. Immunostains for pankeratin, PLAG1, and HMGA2 were negative. The presence of cellular crowding and binuclear chondrocytes \[[Figure 3](#F3){ref-type="fig"}\] supported the final interpretation of the lesion as a low-grade (Grade 1) pulmonary chondrosarcoma.

DISCUSSION {#S3}
==========

Chondrosarcomas of primary lung parenchymal origin are extremely infrequent with most descriptions of the pathology coming almost exclusively from case reports, as depicted in [Table 1](#T1){ref-type="table"}. A literature search of PubMed using the query \[(pulmonary OR lung) AND chondrosarcoma AND primary\] yielded 14 studies with full-text available or sufficient information available in the abstract. Ten additional studies were found through a bibliographic review. Cases that did not originate from lung parenchymal tissue were excluded from the study. Such excluded cases include pulmonary artery, costal, and bronchial chondrosarcomas.

###### 

Literature review of primary pulmonary chondrosarcoma cases

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study primary author, year      Age/sex     Presentation                                                                                                                                         Location                                                   Type               Treatment                                                                                                 Outcome
  ------------------------------- ----------- ---------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------- ------------------ --------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Balanzá, 2016^\[[@ref5]\]^      69/M        Hemoptysis                                                                                                                                           RLL                                                        Myxoid             oracotomy                                                                                                 Complete surgical resection. No evidence of recurrence for 6 months of follow-up

  Jiang, 2016^\[[@ref4]\]^        59/M        Hemoptysis, cough, dyspnea                                                                                                                           RUL                                                        Myxoid             Surgical removal, ifosfamide, doxorubicin                                                                 Distal metastases, Ongoing treatment

  Endicott, 2015^\[[@ref6]\]^     69/M        Acute-onset dyspnea                                                                                                                                  LUL                                                        Myxoid             Sublobar resection                                                                                        Complete surgical resection. No evidence of recurrence for 6 months of follow-up

  Wang, 2014^\[[@ref1]\]^         52/F        Intermittent cough, dyspnea                                                                                                                          LUL                                                        Dedifferentiated   oracotomy                                                                                                 Patient is alive after 36 months of follow-up

  Mei, 2013^\[[@ref7]\]^          20/F        Non-productive cough, chest pain                                                                                                                     LLL                                                        Mesenchymal        Pneumonectomy                                                                                             Lost to follow-up

  Kalhor, 2011^\[[@ref2]\]^       1\. 69/F\   1\. NA\                                                                                                                                              1\. NA\                                                    1\. Hyaline\       1\. NA\                                                                                                   1\. NA\
                                  2. 69/M\    2. NA\                                                                                                                                               2. NA\                                                     2. Myxoid\         2. NA\                                                                                                    2. Decreased, 45 days post-operative\
                                  3. 53/M\    3. NA\                                                                                                                                               3. NA\                                                     3. Myxoid\         3. NA\                                                                                                    3. NA\
                                  4. 51/F     4. NA                                                                                                                                                4. NA                                                      4. Hyaline         4. NA                                                                                                     4. Patient is alive after 36 months of follow-up

  Li, 2011^\[[@ref8]\]^           51/F        Severe anemia                                                                                                                                        LUL                                                        Myxoid             oracotomy, left upper lobectomy with systemic lymph node dissection                                       Smooth recovery, discharged in good condition without anemia after 2 weeks, follow-up every 3 months, no abnormalities32 months post-operative

  Boueiz, 2009^\[[@ref9]\]^       57/F        Exertional dyspnea                                                                                                                                   RLL, posterior mediastinum                                 Myxoid             oracotomy, complete debulking, pleurodesis                                                                Uneventful post-operative course, no recurrence of pleural effusion, declined adjuvant chemotherapy, and lost to follow-up

  Shah, 2007^\[[@ref10]\]^        60/M        Dry cough                                                                                                                                            LLL                                                        Hyaline            oracotomy, recurrence/metastasis treated with radiotherapy, ifosfamide, doxorubicin, surgical resection   Full recovery after treatment of distal metastases.

  Steurer, 2007^\[[@ref11]\]^     49/M        Chest pain, fatigue, weight loss                                                                                                                     LUL                                                        Dedifferentiated   Doxorubicin, ifosfamide, surgical resection                                                               No evidence of further tumor lesions after 30 months of follow-up

  Ichimura, 2005^\[[@ref12]\]^    35/M        Incidental                                                                                                                                           LLL                                                        Myxoid             VATS                                                                                                      Patient is alive after 72 months of follow-up

  Huang, 2002^\[[@ref13]\]^       40/M        Incidental                                                                                                                                           LUL                                                        Mesenchymal        oracotomy                                                                                                 No evidence of recurrence/metastasis after 12 months of follow-up

  Parker, 1996^\[[@ref14]\]^      25/F        Abdominal pain                                                                                                                                       LUL                                                        Hyaline            Surgical excision                                                                                         Patient is alive after 14 months of follow-up

  Hayashi, 1993^\[[@ref15]\]^     73/M        Incidental                                                                                                                                           RML                                                        Hyaline            Surgical resection                                                                                        Metastases to skull, kidneys

  Kurotaki, 1992^\[[@ref16]\]^    45/F        NA                                                                                                                                                   RLL                                                        Mesenchymal        Lobectomy                                                                                                 Patient is alive after 12 months of follow-up

  Stanfield, 1991^\[[@ref17]\]^   78/M        Dull pain in the left chest and shoulder                                                                                                             LUL                                                        Mesenchymal        oracotomy, resection of LUL, 2^nd^and 3^rd^ribs, and adjacent soft tissue                                 Normal post-operative recovery with a significant reduction in cancer-related pain,tumor identified in a subclavian nodule of the chest wall adjacent to surgical incision 2months later

  Watanabe, 1990^\[[@ref18]\]^    67/M        Fever, cough                                                                                                                                         RLL                                                        Myxoid/Hyaline     Lobectomy                                                                                                 No signs of recurrence after 44 months

  Jazy, 1984^\[[@ref19]\]^        1\. 61/F\   1\. Non-productive cough, right-sided pleuritic chest pain.\                                                                                         1\. RLL, lower posterior mediastinum.\                     1\. NA\            1\. Exploratory thoracotomy, radiation, incomplete resection, cyclophosphamide, doxorubicin\              1\. Recurrence 5 months post-operative. Died of cardiac causes 4 months later\
                                  2. 70/M     2. Left-sided chest pain, let scapular pain, left arm pain, left Horner syndrome, signs of cord compression with paraparesis and altered sensorium   2. LUL, extending into epidural space at the level of T2   2. NA              2. Decompressive laminectomy ×2, radiation, physical rehabilitation                                       2. Progressive debilitation, death within 7 months of presentation.

  Sun, 1982^\[[@ref20]\]^         31/F        Wheezing, cough                                                                                                                                      RLL                                                        Myxoid/Hyaline     Pneumectomy, radiotherapy                                                                                 Deceased

  Morgan, 1972^\[[@ref21]\]^      23/F        Incidental                                                                                                                                           RLL                                                        Myxoid             oracotomy, local excision                                                                                 Discharged on post-operative day 9. Doing very well on follow-up 15 months post-operative.

  Rees, 1970^\[[@ref22]\]^        64/M        Cough with purulent sputum                                                                                                                           LUL                                                        Hyaline            Lobectomy                                                                                                 Patient is alive after 48 months of follow-up

  Smith, 1960^\[[@ref23]\]^       53/F        Chronic fatigue, frontal headache, palpitations, nocturia, ankle swelling                                                                            Right lung                                                 NA                 NA                                                                                                        NA

  Lowell, 1949^\[[@ref24]\]^      41/F        Fatigue, anorexia, lower extremity edema, weight loss, dyspnea, tachycardia, palpitations                                                            LLL                                                        Mesenchymal        No treatment, patient decided to forgo thoracotomy                                                        Patient died of expanding the pneumothorax

  Greenspan, 1933^\[[@ref25]\]^   35/F        Chest pain                                                                                                                                           LUL                                                        NA                 None (diagnosed at autopsy)                                                                               Deceased
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

M: Male, F: Female, NA: Not available, RUL: Right upper lobe, RML: Right middle lobe, RLL: Right lower lobe, LUL: Left upper lobe, LLL: Left lower lobe, VATS: Video-assisted thoracoscopic surgery

The incidence of primary pulmonary chondrosarcoma is difficult to estimate as this pathology is frequently misdiagnosed, requiring an extensive clinical history and diagnostic workup to exclude alternative primary origin; thus, it may be underreported in the literature. Patients with pulmonary chondrosarcomas frequently present with symptomatic pulmonary obstruction, dyspnea, and chest pain. The tumors are often centrally located and present with sharp borders. CT scans that demonstrate a well-demarcated, centrally located mass with calcifications may be indicative of pulmonary chondrosarcoma and this pathology should be included in the differential diagnosis of patients with similar presentations to ours \[[Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\].

The presence of calcifications is disputed as a case report claimed calcifications are classically present,^\[[@ref1]\]^ whereas other case reports indicate an absence of calcifications.^\[[@ref2]\]^ Histologically, pulmonary chondrosarcomas are characterized by ill-defined lobules containing differentiated hyaline cartilage with plump nuclei, binucleation, hyperchromasia, and coarse chromatin.^\[[@ref2]\]^ The presence of basophilic myxoid stroma with focal areas of hyaline cartilage may also be seen.^\[[@ref2]\]^ Immunohistochemical studies of the tumors are negative for keratin, CD31, and desmin and are S-100 positive.

To diagnose a primary pulmonary chondrosarcoma, a detailed clinical history and appropriate imaging are essential to exclude the following criteria: Prior history of skeletal neoplasms, a thoracic cage neoplasm, limb amputation, and teratoma.^\[[@ref2]\]^ Furthermore, the presence of the Carney triad (pulmonary chondroma along with gastrointestinal stromal tumor and extra-adrenal paragangliomas) should be excluded.^\[[@ref3]\]^

Regarding treatment, complete surgical resection of the tumor is recommended as malignant cartilage may be observed with mixed epithelial/mesenchymal neoplasms.^\[[@ref2]\]^ Complete resection of the tumor may also prevent misdiagnosis based on improper biopsy specimen as teratomas may resemble pulmonary chondrosarcoma from biopsy location inaccuracy.^\[[@ref4]\]^

A comprehensive review of existing literature on this tumor reveals that these tumors, when treated early, generally respond well to surgical treatment. These tumors have been known to metastasize to distal sites, such as the skull and kidneys, where adjuvant chemotherapy may be more beneficial. Further, investigation and study of the radiological findings in cases of primary pulmonary chondrosarcomas and reported outcomes are needed to establish reliable diagnostic criteria and treatment recommendations.

CONCLUSION {#S4}
==========

Primary pulmonary chondrosarcomas are a rare form of chondrosarcomas as seen in the dearth of cases reported in literature. We report a case which was prompted by the identification of a lung mass when the patient came in for chest X-ray and chest CT for fever, non-productive cough, and weight loss. Diagnostic workup of exclusion and histological analysis confirmed its origin from lung parenchymal tissue. It is necessary to pursue further study of radiological findings of primary pulmonary chondrosarcomas to develop guidelines and criteria to reliably establish its diagnosis.
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